Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
UnitedHealth has substantially underperformed the broader market over the past year amid regulatory and operational challenges, although analysts continue to maintain a cautiously constructive view on the company’s long-term growth prospects.
If it feels like growth stocks can’t continue their outperformance much longer, ignore that feeling. The Vanguard S&P 500 Growth Index Fund Exchange-Traded Fund, home to companies with high sales growth including Nvidia Advanced Micro Devices Microsoft and Eli Lilly is up 13% in the past month. A couple of factors have driven the performance of the growth stocks.
The health insurance and healthcare services giant is early in its turnaround plans.
U.S. stock markets closed mixed on Tuesday following hotter-than-expected key inflation data.
U.S. stock markets closed mixed on Tuesday following hotter-than-expected key inflation data.
UnitedHealth Group Incorporated (NYSE:UNH) is one of the top “blue chip” stocks that were suddenly on fire in April. JPMorgan lifted the price target on UnitedHealth Group Incorporated (NYSE:UNH) to $420 from $389 on April 28, reiterating an Overweight rating on the shares. UnitedHealth Group Incorporated (NYSE:UNH) also received a rating update from Goldman Sachs on […]
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...
UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.
Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...
If it feels like growth stocks can’t continue their outperformance much longer, ignore that feeling. The Vanguard S&P 500 Growth Index Fund Exchange-Traded Fund, home to companies with high sales growth including Nvidia Advanced Micro Devices Microsoft and Eli Lilly is up 13% in the past month. A couple of factors have driven the performance of the growth stocks.
Nvidia and Boeing lead five Dow stocks to watch near buy points this week. Nvidia stock and its peers have rallied in a soaring stock market, with earnings out of the way for some of these names but not for others. Walmart, Goldman Sachs and UnitedHealth also make the cut.
UnitedHealth Group (UNH) has been in focus after first quarter 2026 earnings, a higher full year earnings outlook, and plans to cut prior authorization requirements, while analysts highlighted the stock following these updates. See our latest analysis for UnitedHealth Group. The stock has reacted strongly to the first quarter earnings update and guidance lift, with a 30 day share price return of 20.15% and 90 day share price return of 33.65%. However, the 1 year total shareholder return is...
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 Best Value Stocks to Buy in 2026 According to Warren Buffett. On May 5, UnitedHealth Group Incorporated (NYSE:UNH) announced that it is removing authorization requirements for 30% of healthcare services that previously needed insurer approval. The company said the move builds on several recent commitments aimed […]
Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected.
The most significant insight currently obscured by CVS Health's (CVS) headline revenue growth is a high-stakes transition: the company is attempting to use a temporary surge in insurance profitability to outrun the structural margin pressures facing its pharmacy benefit management (PBM) business.
Tenet Healthcare tops Q1 EPS estimates as admissions and ambulatory growth drive gains, but payer mix pressures and rising costs weigh on margins.
CVS stock is breaking out on Wednesday morning after it posted better-than-expected first-quarter results and raised its full-year outlook. Of CVS Health's three big segments, its health benefits segment saw operating income surge by $1.05 billion, or 53%.
Founded in 1869, Goldman Sachs is the world’s second-largest investment bank by revenue and is ranked 82nd on the Fortune 500 list of the largest U.S. corporations by total revenue. The Wall Street white-glove firm offers financing, advisory services, risk distribution, and hedging for the firm’s institutional and corporate clients. In addition, they produce some ... 5 Goldman Sachs Top Picks for May Are Safe, Pay Dividends With Double-Digit Upside
UnitedHealthcare, part of UnitedHealth Group (NYSE:UNH), plans to remove prior authorization requirements for a large share of healthcare services starting in 2026. The change is intended to cut administrative complexity, while aiming to improve access and affordability for patients and providers. This policy update affects core insurance operations and could influence how hospitals, physicians and patients interact with NYSE:UNH plans. For a company of UnitedHealth Group's scale in US...
The Department of Justice’s 2025 healthcare fraud takedown charged 324 defendants with $14.6 billion in losses — more than double the $6 billion record set one year earlier. For Medicare beneficiaries, it is increasingly a line item: a copay for a service the patient never received, a denied PET scan because records show one was ... The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements
The insurer and healthcare giant is getting back to a solid profit footing.
CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.
Ensign Group tops Q1 EPS estimates as occupancy gains and acquisitions fuel growth, while higher costs and a slight revenue miss temper results.
Heather Cianfrocco is joining the Pittsburgh-based healthcare company as its chief operating officer effective immediately.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
